Prevention of cardiovascular events. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Brachial Artery Carotid Arteries Tunica Media Ankle Endothelium, Vascular Tunica Intima Cardiovascular System Coronary Vessels Femoral Artery

Organisms1

Chlamydophila pneumoniae

Diseases58

Cardiovascular Diseases Myocardial Infarction Stroke Coronary Artery Disease Hypertension Acute Coronary Syndrome Coronary Disease Diabetes Mellitus, Type 2 Atherosclerosis Diabetic Angiopathies Kidney Failure, Chronic Renal Insufficiency, Chronic Peripheral Vascular Diseases Calcinosis Plaque, Atherosclerotic Diabetes Complications Recurrence Angina Pectoris Death, Sudden, Cardiac Kidney Diseases Heart Failure Dyslipidemias Disease Progression Carotid Artery Diseases Thrombosis Hypercholesterolemia Diabetes Mellitus Metabolic Syndrome X Albuminuria Death Peripheral Arterial Disease Hypertrophy, Left Ventricular Myocardial Ischemia Chronic Disease Inflammation Angina, Unstable Vascular Calcification Heart Diseases HIV Infections Hyperlipidemias Cerebrovascular Disorders Atrial Fibrillation Coronary Stenosis Obesity Hemorrhage Arteriosclerosis Aortic Diseases Diabetic Nephropathies Arteriosclerosis Obliterans Vascular Diseases White Coat Hypertension Postoperative Complications Coronary Restenosis Intermittent Claudication Asymptomatic Diseases Ventricular Dysfunction, Left Ischemic Attack, Transient Angina, Stable

Chemicals and Drugs57

Biological Markers Hydroxymethylglutaryl-CoA Reductase Inhibitors Platelet Aggregation Inhibitors C-Reactive Protein Antihypertensive Agents Aspirin Heptanoic Acids Pravastatin Anticholesteremic Agents Cholesterol, LDL Pyrroles Ticlopidine Fluorobenzenes Hypolipidemic Agents Natriuretic Peptide, Brain Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents Chlorthalidone Cholesterol, HDL Fosinopril Amlodipine Cystatin C Angiotensin II Type 1 Receptor Blockers Simvastatin 1-Alkyl-2-acetylglycerophosphocholine Esterase Creatinine Lipids Hypoglycemic Agents Tetrazoles Anticoagulants Sulfonamides Cyclooxygenase 2 Inhibitors Atenolol Niacin Phospholipases A2, Secretory Blood Glucose Perindopril Azetidines Benzimidazoles Ramipril Anti-Inflammatory Agents, Non-Steroidal Cholesterol Fibrinogen Placebos Adrenergic beta-Antagonists Triglycerides Hemoglobin A, Glycosylated Particulate Matter Diuretics Fatty Acids, Omega-3 Indapamide Margarine Calcium Channel Blockers Fibrinolytic Agents Purinergic P2Y Receptor Antagonists Hydrochlorothiazide Homocysteine

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Risk Factors Follow-Up Studies Prospective Studies Risk Assessment Proportional Hazards Models Predictive Value of Tests Incidence Treatment Outcome Prognosis Cohort Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Double-Blind Method Blood Pressure Risk Renal Dialysis Multivariate Analysis Drug Therapy, Combination Coronary Angiography Retrospective Studies Severity of Illness Index Chi-Square Distribution Prevalence Angioplasty, Balloon, Coronary Cause of Death Odds Ratio Logistic Models Survival Rate Blood Pressure Monitoring, Ambulatory Survival Analysis Hospitalization Glomerular Filtration Rate Carotid Intima-Media Thickness Ankle Brachial Index Endpoint Determination Cross-Sectional Studies Case-Control Studies Longitudinal Studies Myocardial Revascularization Regression Analysis Clinical Trials as Topic Percutaneous Coronary Intervention ROC Curve Questionnaires Disease-Free Survival Electrocardiography Stents Platelet Function Tests Registries Obesity Research Design Analysis of Variance Blood Pressure Determination Propensity Score Patient Selection Epidemiologic Methods Mortality Body Mass Index Multicenter Studies as Topic Estrogen Replacement Therapy Coronary Artery Bypass Placebos Mass Screening Drug Chronotherapy Heart Rate Kidney Function Tests Diet Therapy Tomography, X-Ray Computed Sensitivity and Specificity Pulse Wave Analysis Echocardiography Administration, Oral Perioperative Care Linear Models Ultrasonography, Interventional Confidence Intervals Perioperative Period Stroke Volume Pulse Blood Flow Velocity Product Surveillance, Postmarketing Drug-Eluting Stents Reproducibility of Results Morbidity Population Surveillance

Psychiatry and Psychology5

Risk Reduction Behavior Smoking Life Style Patient Compliance Health Knowledge, Attitudes, Practice

Phenomena and Processes24

Time Factors Blood Pressure Risk Chi-Square Distribution Odds Ratio Glomerular Filtration Rate Carotid Intima-Media Thickness Vascular Stiffness Circadian Rhythm Obesity Dose-Response Relationship, Drug Vasodilation Body Mass Index Pulsatile Flow Heart Rate Postmenopause Sensitivity and Specificity Systole Exercise Stroke Volume Pulse Blood Flow Velocity Genotype Platelet Aggregation

Disciplines and Occupations3

Evidence-Based Medicine Research Design Preventive Medicine

Anthropology, Education, Sociology and Social Phenomena6

Centers for Disease Control and Prevention (U.S.)Age Distribution Sex Distribution Health Education Exercise Forecasting

Technology, Industry, Agriculture2

Dietary Supplements Margarine

Information Science8

Incidence Prevalence Cause of Death Survival Rate Questionnaires Registries Mortality Morbidity

Named Groups1

Asian Continental Ancestry Group

Health Care66

Risk Factors Primary Prevention Follow-Up Studies Prospective Studies Risk Assessment Proportional Hazards Models Predictive Value of Tests Incidence Secondary Prevention Treatment Outcome Cohort Studies Kaplan-Meier Estimate Randomized Controlled Trials as Topic Double-Blind Method Risk Centers for Disease Control and Prevention (U.S.)Multivariate Analysis Retrospective Studies Severity of Illness Index Comorbidity Chi-Square Distribution Age Factors Prevalence Cause of Death Odds Ratio Accident Prevention Logistic Models Survival Rate Survival Analysis Hospitalization Cross-Sectional Studies Sex Factors Case-Control Studies Longitudinal Studies Regression Analysis Practice Guidelines as Topic Clinical Trials as Topic Cost-Benefit Analysis ROC Curve Questionnaires Disease-Free Survival Registries Analysis of Variance Propensity Score Patient Selection Epidemiologic Methods Health Promotion Mortality Body Mass Index Multicenter Studies as Topic Preventive Health Services Age Distribution Sex Distribution Mass Screening Sensitivity and Specificity Health Education Patient Compliance Health Knowledge, Attitudes, Practice Perioperative Care Linear Models Confidence Intervals Epidemiologic Factors Perioperative Period Reproducibility of Results Morbidity Population Surveillance

Geographicals7

Japan United States Germany Italy South Dakota Netherlands Denmark

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Cardiovascular Diseases Risk Factors Primary Prevention Follow-Up Studies Prospective Studies Myocardial Infarction Risk Assessment Stroke Proportional Hazards Models Predictive Value of Tests Coronary Artery Disease Biological Markers Incidence Hydroxymethylglutaryl-CoA Reductase Inhibitors Secondary Prevention Treatment Outcome Hypertension Prognosis Cohort Studies Platelet Aggregation Inhibitors C-Reactive Protein Acute Coronary Syndrome Kaplan-Meier Estimate Time Factors Randomized Controlled Trials as Topic Coronary Disease Diabetes Mellitus, Type 2 Antihypertensive Agents Double-Blind Method Blood Pressure Aspirin Heptanoic Acids Risk Atherosclerosis Pravastatin Diabetic Angiopathies Kidney Failure, Chronic Anticholesteremic Agents Cholesterol, LDL Japan Renal Insufficiency, Chronic Renal Dialysis Centers for Disease Control and Prevention (U.S.)United States Pyrroles Multivariate Analysis Ticlopidine Fluorobenzenes Peripheral Vascular Diseases Calcinosis Plaque, Atherosclerotic Hypolipidemic Agents Drug Therapy, Combination Diabetes Complications Recurrence Angina Pectoris Death, Sudden, Cardiac Coronary Angiography Brachial Artery Kidney Diseases Retrospective Studies Severity of Illness Index Heart Failure Comorbidity Chi-Square Distribution Age Factors Natriuretic Peptide, Brain Dyslipidemias Prevalence Angiotensin-Converting Enzyme Inhibitors Disease Progression Cardiovascular Agents Carotid Artery Diseases Angioplasty, Balloon, Coronary Carotid Arteries Cause of Death Odds Ratio Accident Prevention Chlorthalidone Logistic Models Survival Rate Thrombosis Cholesterol, HDL Blood Pressure Monitoring, Ambulatory Hypercholesterolemia Survival Analysis Hospitalization Diabetes Mellitus Glomerular Filtration Rate Metabolic Syndrome X Carotid Intima-Media Thickness Albuminuria Ankle Brachial Index Fosinopril Tunica Media Endpoint Determination Death Peripheral Arterial Disease Cross-Sectional Studies Risk Reduction Behavior

No FAQ available that match "prevention of cardiovascular events"